Prostate carcinoma (PCA) is the most frequently diagnosed malignancy in American men. PCA at advanced stages can both proliferate abnormally and resist apoptosis. Among the many known signal transduction pathways, phosphatidylinositide-3'OH kinase (PI3-kinase) has been shown to play an important role in cell survival and resistance to apoptosis. In this study, we investigate the involvement of Etk/Bmx, a newly discovered tyrosine kinase that is a substrate of PI3-kinase, in protection of prostate cancer cells from apoptosis. Parental LNCaP cells and two derivative cell lines, one overexpressing wild type Etk (Etkwt) and the other expressing a dominant negative Etk (EtkDN), were used to study the function of Etk. The cells were treated with photodynamic therapy (PDT), a newly approved cancer treatment which employs a photosensitizer and visible light to produce an oxidative stress in cells, often leading to apoptosis. Our results indicate that PDT induces apoptosis in LNCaP cells, as measured by DNA fragmentation and by cleavage of poly(ADP-ribose) polymerase (PARP), and moreover, the extent of apoptosis was much reduced in Etkwt cells as compared to LNCaP or EtkDN cells. Assay of overall cell viability con®rmed that Etkwt cells were considerably less sensitive to PDT than were the parental LNCaP or EtkDN cells. Similar results were found in response to thapsigargin (TG). A speci®c inhibitor of PI3-kinase, LY294002, abolished Etk activity and markedly increased TG-induced PARP cleavage. The results suggest that Etk/Bmx is an ecient eector of PI3-kinase and that the newly described PI3-kinase/Etk pathway is involved in the protection of prostate carcinoma cells from apoptosis in response to PDT or TG.
Introduction
Prostate carcinoma (PCA) is the most frequently diagnosed malignancy of men in the United States.
The molecular and genetic events underlying neoplastic transformation and progression in the prostate are not well understood. PCA at advanced stages, like other aggressive tumors, has acquired the ability not only to proliferate but also to resist apoptosis (Tenniswood, 1997; Tang and Porter, 1997) . We have been interested in the mechanism of PCA resistance to apoptosis. Among the several major signal transduction pathways, the PI3-kinase pathway has been strongly implicated in cell survival and resistance to apoptosis Alessi and Cohen, 1998; Ptasznik et al., 1997) . How PI3-kinase aects cell survival has been a subject of intensive investigation. It was shown that the metabolic products of PI3-kinase, phosphatidyl inositol phosphates, bind a protein modular structure, called the pleckstrin-homology (PH) domain . Several PH-domain-containing proteins are found to be eectors for PI3-kinase (Franke et al., 1995; Cross et al., 1995; August et al., 1997; Li et al., 1997; Qiu et al., 1998) . Of particular relevance is Akt/PKB, a serine/ threonine kinase with an N-terminal PH domain, which was recently shown to phosphorylate and inactivate Bad, a protein involved in the apoptosis pathway. This oers one mechanism whereby PI3-kinase can reduce apoptosis del Peso et al., 1997; Dudek et al., 1997) . Here we describe the action of a PH-domain containing tyrosine kinase, Etk/Bmx, in the protection of PCA from apoptotic death.
Etk/Bmx is a newly discovered tyrosine kinase, commonly expressed in prostate epithelial and carcinoma cells. Our previous studies showed that this kinase is activated by PI3-kinase. Etk belongs to the Btk and Itk family of kinases. Btk (Bruton's tyrosine kinase) and Itk have been studied extensively in recent years and shown to play signi®cant roles in B and T cell development by channeling B and T-cell receptor-mediated signals and protecting these cells from apoptosis. Btk was discovered as a gene whose germline mutation in the PH domain leads to XLA, X-linked agammaglobulinemia. Mice with a targeted deletion of this locus develop xid, an acquired immunode®ciency disease. Overexpression of a constitutively active Btk induces morphological transformation and protects the transfected cells from apoptosis (Li et al., 1995) . Likewise, Itk is highly expressed in T-cells and involved in T-cell development. Interestingly, Etk is not expressed in either B or T cells, but rather in epithelial cells, endothelial cells, and monocytes/macrophages (Qiu et al., 1998; Tamagnone et al., 1994; Kaukonen et al., 1996; Weil et al., 1997) . It is tempting to think that Etk plays a similar role in the growth, development and antiapoptosis of epithelial cells. In this report we present data that suggest that Etk is involved in protection of prostate cancer cells from apoptosis.
To study the anti-apoptotic role of Etk, we used two approaches to induce apoptosis in LNCaP, an androgen-responsive PCA cell line. The ®rst approach is PDT (photodynamic therapy), a novel cancer treatment that utilizes a photosensitizing drug, visible light, and oxygen to produce reactive oxygen species, including singlet oxygen, in cellular targets; the resultant oxidative stress leads to cell death and tumor ablation (Moan and Berg, 1992; Henderson and Dougherty, 1992; Hasan and Parrish, 1997) . The initial targets of PDT damage are thought to reside in membranes. Although PDT causes a direct activation of the ®nal stages of apoptosis (Kessel et al., 1997; Kessel and Luo, 1999; Oleinick and Evans, 1998) , the sensitivity of cells to PDT can vary between closely related cell lines as a function of the expression of particular genes. Thus, HL60 cells expressing wild-type p53 were more sensitive to cell killing by PDT than were HL60 cells in which p53 genes were deleted or mutant, although all lines underwent a rapid apoptotic response (Fisher et al., 1997) . Chinese hamster ovary cells expressing a human Bcl-2 gene were partially resistant to apoptosis and to overall cell death after PDT sensitized by the phthalocyanine Pc 4 (He et al., 1996) . PDT is also an ecient activator of a variety of signal transduction pathways (Agarwal et al., 1993; Ryter and Gomer, 1993; Xue et al., 1997; Tao et al., 1996; Separovic et al., 1997) , although the functions, if any, of these pathways in mediating or protecting from cell death have yet to be fully de®ned.
In addition to PDT, thapsigargin (TG) is frequently used to induce apoptosis in cancer cells, including prostate carcinoma cell lines (McConkey et al., 1996) . The malignant transformation of prostate cancer cells has been found to correlate with their resistance to TG. TG inhibits an ATP-gated calcium pump controlling the in¯ux of calcium from the cytosol to the endoplasmic reticulum (ER), thereby depleting the calcium pool of the ER and activating the apoptosis pathway . This process is accompanied by an induction of GRP78 expression and caspase activation, and cells can be rescued by overexpression of Bcl2 (Qi et al., 1997; Liu et al., 1997) . Thus, although PDT and TG take dierent routes to initiate the apoptotic process, there is a converging of pathways in the downstream events of apoptosis.
In this report, we show that LNCaP cells are sensitive to apoptosis induced by either PDT or TG, as evidenced by DNA fragmentation, cleavage of poly(ADP-ribose) polymerase (PARP), and a cell viability test. We further demonstrate that PI3-kinase and its downstream substrate Etk are involved in the protection of LNCaP cells from apoptosis induced by these agents. Overexpression of wild-type Etk renders the cell more resistant to apoptosis, whereas overexpression of a kinase-dead, dominant-negative Etk sensitizes cells toward apoptosis. Our ®nding de®nes a new PI3-kinase pathway involved in survival and possibly tumor resistance found in malignant PCA.
Results

Development of LNCaP cells overexpressing wild-type and mutant Etk
We recently reported that Etk is an eector of PI3-kinase and plays an important role in IL6-induced signaling in human prostate cancer cells (Qiu et al., 1998) . PI3-kinase has been shown to be important for the survival of a number of dierent cell types . The purpose of this study was to investigate whether Etk as well as PI3-kinase are involved in protection of prostate cancer cells from apoptosis. To this end, we developed two LNCaP cell lines overexpressing, respectively, a wild-type Etk (LNCaP-Etkwt) and a dominant-negative mutant of Etk (LNCaP-EtkDN). Both molecules were tagged with a T7-epitope at the N-termini. The dominantnegative (DN) Etk carries a substitution of K444 with R in the catalytic domain which abolishes the kinase activity and in addition, a second mutation in the PH domain which, by analogy with Btk, increases the anity toward lipid. In transient transfections, EtkDN has proven highly eective in reducing the endogenous Etk kinase activity, presumably by sequestering the activating lipid moiety (Qiu et al., 1998) . We show here that EtkDN is equally eective when stably transfected into the LNCaP cell line. The result is illustrated in Figure 1a , using an in vitro kinase assay of immunoprecipitated Etk from the various cell lines. The parental cells (lane LNCaP) display a basal level of endogenous Etk activity in the presence of serum. This activity is completely absent in EtkDN-expressing (Figure 1b ) with anti-T7 antibody, which detects ectopically tagged Etk, reveals that similar amounts of wild-type and dominant-negative Etk were expressed in the two cell lines. These results set the stage for the analysis of the anti-apoptotic eect of Etk.
PDT-induced apoptosis and the protection by Etk
Photodynamic treatment (PDT) is a potent inducer of apoptosis in many types of cells (Oleinick and Evans, 1998) . Figure The execution phase of apoptosis consists of the activation of a series of cysteine-containing proteases, termed caspases, acting on substrates with speci®c four-amino acid sequences terminating in aspartic acid. One of the substrates for the caspases is PARP (Lazebnik et al., 1994; Kaufmann et al., 1993) , which has been used fruitfully to monitor the progression of apoptosis. Cleavage of PARP at its DEVD motif results in the generation of an M r 90 000 fragment from the M r 116 000 native enzyme. To further characterize the block in the apoptotic pathway in Etk-overexpressing cells, the same treated cells used for Figure 2 were analysed for the extent of PARP cleavage by Western blotting with an anti-PARP antibody (Figure 3 ). For cells not treated with PDT, the majority of the PARP migrated at the position of intact PARP; a faint band corresponding to the cleavage product was observed, indicating a low level of constitutive cleavage of PARP. Four hours after PDT, PARP cleavage increased markedly in LNCaP and EtkDN cells. By contrast, only a slight increase in cleaved PARP was observed in PDT-treated Etkwt cells. The extent of PARP cleavage was quanti®ed by densitometry and is shown at the bottom of Figure 3 .
Cell killing by PDT is dependent on both the light uence and the photosensitizer concentration. For the present study, the Pc 4 dose in the medium was held constant, but it was important to ascertain whether or not the uptake of dye into the three cell lines diered as a result of the presence of Etk protein. Cultures of the three cell lines were incubated with various concentrations of Pc 4 overnight, then cell-associated dye was extracted and its level was estimated by 2 of red light. Four hours later, the cells were collected. The total cell extracts were subjected to SDS ± PAGE followed by Western blotting with anti-PARP antibody. The bottom of the ®gure shows the percentage of PARP cleaved after PDT treatment in three cell lines calculated as described in Materials and methods. Similar results were observed in at least three independent experiments, in which the standard deviations were415% of the mean values absorption spectrophotometry. The uptake of Pc 4 increased linearly with the concentration in the range of 0.5 ± 2 mM, and there was no signi®cant dierence among the three cell lines in the uptake of Pc 4 (data not shown). The result indicates that the lower level of apoptosis in Etkwt cells did not result from a reduced uptake of Pc 4, but from the function of Etk.
We next investigated the overall cell viability after PDT treatment, using the WST-1 assay, which measures the reduction of dye by intact mitochondria. Based on this assay, dose-dependent killing was found in all three cell lines. However, the Etkwt cells were considerably less sensitive to PDT than the parental LNCaP cells, and the EtkDN cells ( Figure  4 ). This ®gure also shows that the cells expressing dominant-negative Etk were more sensitive to killing by PDT than were the parental cells. Taken together, these data suggest that Etk controls the sensitivity of LNCaP toward PDT-induced apoptosis.
Thapsigargin-induced apoptosis and protection by Etk
In order to determine the generality of the role of Etk as an inhibitor of apoptosis, another potent inducer of apoptosis, thapsigargin (TG), which acts via the inhibition of the endoplasmic reticulum calcium ion pump, was studied in the three cell lines. Figure 5a shows the DNA fragmentation patterns at 48 h after addition of TG to the cultures. Both EtkDN and LNCaP cells are sensitive to TG-induced DNA degradation, whereas Etkwt cells are resistant. The PARP cleavage analysis showed a similar trend ( Figure  5b ). When the cells were incubated in 300 nM TG for 20 h, there was little or no PARP cleavage in any of the cell lines, compared to the untreated control. At 40 h, signi®cant PARP cleavage was detected in all three cell lines with EtkDN cells displaying the highest level of cleavage (59%) and LNCaP cells the intermediate level (30%). PARP cleavage in Etkwt cells was the lowest at 10%. Similar graded dierences were found in the cell viability analysis (Figure 5c ). For instance, only 5% of EtkDN cells survived TG treatment for 48 h, whereas close to 50% of Etkwt cells remained viable. The parental cell line had an intermediate survival rate (10%). These data, like those described for PDT, provide strong indications that Etk activity is important in the resistance of LNCaP cells to apoptosis.
PI3-kinase, Etk and anti-apoptosis
PI3-kinase has been shown to be very important for the anti-apoptotic response and survival of a number of dierent cell types . Previously, we showed that endogenous Etk is activated by PI3-kinase, which is in turn activated by growth factors present in the serum. If Etk is involved in antiapoptosis, as suggested by the above data, we would predict that inactivation of PI3-kinase, which diminishes Etk activity, should sensitize cells toward apoptosis. One eective way of inactivating PI3-kinase is treatment with the PI3-kinase inhibitor, LY294002. Figure 6a shows Etk activity in parental LNCaP cells. In serum-starved LNCaP (lane 1), very little Etk activity was detected by the in vitro kinase assay. In the presence of serum (lane 2), Etk activity was stimulated, consistent with data shown in Figure 1 . The serum-induced Etk activity was abolished upon treatment with LY294002 (lane 3), demonstrating that Etk activation requires PI3-kinase activity. PARP cleavage was then used to assess the apoptosis state of cells treated with LY294002 (Figure 6b ). Cells were treated with 300 nM TG for 20 h, a time point at which little induction of PARP cleavage was detected as compared to the basal level (Figure 5b ). It is evident from Figure 6b that addition of LY294002 to TG treated LNCaP cells resulted in markedly accelerated apoptosis (Figure 6b, lanes 3 and 4) . Evidence that the enhanced cleavage was not due to LY294002 treatment per se is shown by the control in lane 2 where cells treated with LY294002 but without TG gave the basal cleavage pattern. The data thus implicate PI3-kinase and its eector in the protection of LNCaP cells from apoptosis.
Discussion
There is considerable evidence suggesting that the PI3-kinase pathway is involved in cell survival and tumor resistance to therapeutics. This connection, however, has not been established in prostate cancer cells. Recently, we reported the identi®cation of Etk/Bmx, a PH-domain-containing tyrosine kinase, as a new PI3-kinase eector in prostate epithelial cells. In this study, we set out to determine the protective role of PI3-kinase and Etk in apoptosis of the prostate cancer cell line, LNCaP. We chose two very dierent apoptosis inducing agents, PDT and TG, both shown to be eective in inducing apoptosis in cancer cell lines. PDT works through oxidative damage to membranes, whereas TG acts as a calcium-gate inhibitor. PDT-induced apoptosis appears to involve the release of ceramide (Separovic et al., 1997) and the activation of JNK and p38/HOG (Oleinick and Evans, 1998) . PDT-induced apoptosis is also characterized by a very rapid triggering of the terminal events (Agarwal et al., 1991) , which may result from direct oxidative damage to the mitochondrial membrane (Kessel et al., 1997; Kessel and Luo, 1999) . TG, on the other hand, depletes the calcium pool of the ER. Both pathways activate GRP78, a chaperone protein (Gomer et al., 1991; Li et al., 1993) and can be blocked by overexpression of Bcl2 (He et al., 1996; Qi et al., 1997; Liu et al., 1997) . We show here that Etk is able to protect LNCaP cells from apoptosis induced by either agent. Exactly how Etk counteracts the eects of these two dierent agents is not clear. Recently, it was shown that Etk/Bmx is a potent activator of STAT3, a transcription factor which is known to be involved in anti-apoptosis and oncogenic transformation and with potential to augment the expression of Bcl-XL (R Jove, personal communication) and possibly Bcl2 (Fukada et al., 1996) , thereby eliciting antiapoptotic eects.
Taken in the context of the work of McConkey et al. (1996) , our data suggest that the PI3-kinase/Etk pathway may also be involved in the progression of prostate carcinoma. These authors isolated variants of LNCaP cells with dierent metastatic potentials and found that the more malignant phenotypes correlated with the higher resistance to TG-induced apoptosis. Thus, genetic or epigenetic alterations of the PI3-kinase pathway and Etk may be relevant to oncogenic transformation of prostate cancer cells. In this regard, it is interesting to note that a constitutively activated PI3-kinase catalytic subunit was recently identi®ed as an oncoprotein of a retrovirus and as the putative oncogene locus of ovarian cancers (Iwabuchi et al., 1995) . The present data draw our attention to the possible involvement of the PI3-kinase pathway in prostate carcinogenesis.
Our studies also provide new insights regarding the PI3-kinase pathway and de®ne a new component involved in anti-apoptosis. A number of proteins containing a PH domain are shown to bind phosphatidyl inositol polyphosphates and to be activated by PI3-kinase. These include rac-GEF, unconventional PKCs, Akt/PKB, PDK2 and the Btk family of tyrosine kinases (Franke et al., 1995; Cross et al., 1995; August et al., 1997; Li et al., 1997; Qiu et al., 1998; Ma et al., 1998; Falasca et al., 1998; Van Lint et al., 1998) . Much of the attention has recently been focused on Akt as a protector against apoptosis. Accumulating evidence suggests that upon activation by PI3-kinase, Akt phosphorylates Bad, a dimerization partner of Bcl-XL. The phosphorylated Bad is sequestered by the chaperone protein 14-3-3, and releases Bcl-XL. The free Bcl-XL in turn dimerizes with and sequesters Bax, leaving few Bax dimers to trigger apoptosis. These studies were carried out in IL3-responsive hematopoietic cells and neuronal cells, and it is not clear whether the principle is directly applicable to prostate cancer cells. We found that Akt is expressed in LNCaP cells, but its activation by a PI3-kinase agonist is modest (data not shown). This prompted us to look for other candidate pathways by which PI3-kinase mediates its anti-apoptosis eects. We were helped by a tyrosine kinase expression pro®le that we have developed for prostate cancer cells. This pro®le identi®ed Etk as a potential PI3-kinase eector by virtue of its PH domain. Although the present data provide strong evidence that Etk is involved in prevention of apoptosis in LNCaP cells, they do not exclude the participation of the Akt pathway. In fact, it is likely that Akt and Etk act synergistically or in parallel to promote cell survival. Experiments are in progress to study whether Etk and Akt pathways interact or converge with each other. The induction of apoptosis by PDT occurs much more rapidly than that following TG treatment. The rapid induction of apoptosis has been observed in many types of cells with some lymphoid cell lines producing extensive DNA fragmentation in less than 1 h (Agarwal et al., 1991; Oleinick and Evans, 1998) . It has been proposed that the exceptionally ecient entry of PDT-treated cells into apoptosis results from direct damage to mitochondria (Kessel et al., 1997; Kessel and Luo, 1998) . The resultant immediate release of cytochrome C would then initiate the terminal irreversible phase of apoptosis (Kroemer et al., 1998; Liu et al., 1996) . The present results, as well as the observed inhibition of PDT-induced apoptosis by inhibition of phospholipase C (Agarwal et al., 1993) or p38/HOG, a stress activated kinase (Oleinick et al., 1998) , implicate these signal pathways in the control of apoptosis even when there is direct mitochondrial damage.
In summary, in this report, we have elucidated a new pathway involved in protection of a prostate carcinoma cell line from apoptosis. Our data show that PI3-kinase and its eector Etk function to render LNCaP cells more resistant to apoptosis induced by PDT or by TG. This ®nding is in resonance with the observations by others that Etk's hematopoietic analogs, Btk and Itk, are also strongly implicated in controlling the apoptosis process. Thus, PI3-kinase utilizes at least one PH-domain-containing tyrosine kinase (Etk) and one PH-domain-containing serine/threonine kinase (Akt) to mediate its anti-apoptosis function.
Materials and methods
Cell culture
LNCaP cells (ATCC) were grown in RPMI 1640 medium containing 10% fetal bovine serum (FBS). Etk-overexpressing cells (Etkwt) and Etk dominant-negative cells (EtkDN) were developed and selected as described (Qiu et al., 1998) and grown in RPMI 1640 medium with 10% FBS and 500 mg/ml of G418. The cultures were grown in a humidi®ed atmosphere at 378C with 5% CO 2 .
Photodynamic treatment
The phthalocyanine photosensitizer Pc 4, HOSiPcOSi(CH 3 ) 2 (CH 2 ) 3 N(CH 3 ) 2 , was provided by Drs Ying-syi Li and Malcolm E Kenney, Case Western Reserve University Department of Chemistry. It was dissolved in dimethyl formamide to 0.5 mM. Cells were loaded with Pc 4 by addition of an aliquot (1 ml per ml) of the stock solution to the culture medium *18 h before irradiation. In preparation for irradiation, the dye-containing medium was removed and replaced with 3 ml of Hank's balanced salt solution with Ca 2+ and Mg
2+
. The light source was a 500-W tungsten-halogen lamp with a 600-nm long-pass ®lter. The¯uence rate was 75 W/m 2 . All irradiations were performed at room temperature, and the temperature during irradiation did not exceed 348C.
Cellular uptake of Pc 4
Cultures were treated with various concentrations of Pc 4 for 18 h at 378C. Then cells were trypsinized, an aliquot was counted, and the remaining cells were collected onto a glass ®ber ®lter. After air-drying the ®lters, Pc 4 was dissolved in 5 ml 100% ethanol and quanti®ed by absorption spectrophotometry at l=666 nm. The concentration of cellassociated Pc 4 in the extract was calculated assuming e=2.4610
5 .
Determination of cell viability
Cells were seeded into 96-well microculture plates at 1610 4 cells/well and allowed to attach overnight. For PDT, the medium was removed and replaced with fresh medium with or without 0.5 mM Pc 4. The cells were incubated for *18 h, then irradiated at various¯uences. After irradiation, cells were incubated for an additional 24 h. For TG treatment, cells were incubated in 200 or 300 nM TG for 48 h. Cell viability was measured using the tetrazolium salt WST-1 (Boehringer Mannheim) according to the manufacturer's instructions.
DNA fragmentation analysis
Cells were collected at various times after PDT or TG treatment. DNA isolation and gel electrophoresis were performed as previously described (Agarwal et al., 1991) . Brie¯y, cell pellets were resuspended in 500 ml of a solution containing 16SSC and 10 mM EDTA, then 1% sodium lauryl sarkosinate and 0.1 mg/ml proteinase K were added, and the mixture was incubated at 508C for at least 2 h. The DNA was precipitated by addition of 2 volumes of absolute ethanol, resuspended in 200 ml TE, and brie¯y treated with 1 mg/ml RNase before loading onto a 1.5% agarose gel. After electrophoresis, the gel was stained with 0.5 mg/ml ethidium bromide and photographed under UV light.
Western blot analysis for PARP cleavage
Following PDT and TG treatment, cells were lysed and sonicated in a solution containing 0.5% sodium deoxycholate, 0.2% SDS, 1% Triton X-100, 5 mM EDTA, 10 mg/ml leupeptin, 10 mg/ml aprotinin, and 1 mM phenylmethyl sulfonyl¯uoride in phosphate buered saline. An equal volume of 26SDS sample buer (125 mM Tris, pH 6.8, 4% SDS, 10% mercaptoethanol, and 20% glycerol) was added to the cell lysate. Equivalent amounts of protein were loaded onto an 8% polyacrylamide gel, subjected to electrophoresis, transferred to a PVDF membrane, and probed with a monoclonal anti-PARP antibody (a gift of C Whitacre and NA Berger, Department of Medicine, CWRU) or an antiactin antibody (from Amersham, Arlington Heights, IL, USA) overnight at 48C. The immune complexes were detected by ECL system (Amersham, Arlington Heights, IL, USA). The anti-PARP antibody recognizes an epitope in the NAD-binding domain and thus detects intact M r 116 000 PARP and the M r 90 000 cleavage product. The percentage of the total PARP cleaved in each lane was calculated as follows:
%PARP cleaved intensity of M r 90 000 PARP bands intensity of M r 90 000 bands intensity of M r 16 000 bands
ÂIHH
Immunoprecipitation
Cells were harvested and lysed for 30 min in 1 ml of ice-cold lysis buer (0.5% NP-40, 1% Triton X-100, 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM sodium orthovanadate, 0.5 mM PMSF, 3 mg/ml aprotinin and 1 mg/ml leupeptin). The cleared cell extracts were incubated with an Etk antibody described previously (Qiu et al., 1998) overnight at 48C followed by incubation with 10 ml of protein A+G Sepharose beads for 1 h. The immunoprecipitates were washed three times with ice-cold lysis buer. The bound proteins were eluted from the beads in SDS sample buer and separated on a 7.5% SDS ± PAGE gel, then transferred and Western blotted.
In vitro kinase assay
Assay of the kinase activity of Etk was performed as described previously (Qiu et al., 1998) . Brie¯y, the immunoprecipitates were washed twice with PAN buer (20 mM PIPES, pH 7.0, 100 mM NaCl) and resuspended in 20 ml of kinase reaction buer (30 mM PIPES, pH 7.0, 10 mM MnCl 2 , 10 mM ATP, 1 mM NaVO 4 and 10 mCi g-32 P-ATP) containing 5 mg enolase (Sigma). The reaction mixture was incubated at room temperature for 10 min and stopped by adding an equal volume of 26SDS sample buer. The samples were separated and detected by autoradiography.
